ACTIVE

Cytopat

Export PDF

Financial year 2025 · closed on 30/06/2025

Net result

20,2 k €

+181.1% YoY

Gross margin

934,6 k €

+15.2% YoY

Equity

438,7 k €

+2.0% YoY

Workforce

14,4 ETP

+4.3% YoY

What does Cytopat do?

Cytopat is a Private limited company incorporated in 1982. Its main activity is: Pre-primary education. Its registered office is in Antwerpen. It employs on average 14,4 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0423.639.481

Incorporation

15/11/1982

Legal form

Private limited company

Registered office

Corneel Franckstraat 24
2100 Antwerpen · FlandreSee on map

Contributed capital

60 000,10 €

Latest accounts

30/06/2025

Average workforce

14,4 ETP

Activities (NACE)

85141Pre-primary education· main 86901Other human health activities 86910Other human health activities

Joint committees (3)

30502
330
33004

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 16 financial years

	2025		2024		2023		2022		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007
Income statement
Gross margin	934,6 k €	+15.2%	811,6 k €	-1.0%	819,5 k €	+14.5%	715,5 k €	+5.6%	677,7 k €	-1.8%	690,4 k €	-5.0%	726,9 k €	+3.3%	703,6 k €	-1.5%	714,4 k €	+0.0%	714 k €	+5.0%	679,8 k €	+7.5%	632,3 k €	-16.9%	761,1 k €	+23.1%	618,2 k €	+9.7%	563,7 k €	+15.0%	490,1 k €
EBITDA	44,9 k €	+662%	-8 k €	-179%	10,2 k €	-86.2%	73,6 k €	-4.8%	77,3 k €	-24.5%	102,4 k €	-27.8%	141,8 k €	+11.0%	127,8 k €	-12.1%	145,4 k €	+18.7%	122,5 k €	-7.6%	132,6 k €	+17.2%	113,1 k €	-39.6%	187,1 k €	+63.4%	114,5 k €	+11.4%	102,8 k €	+13.6%	90,5 k €
Operating result	20,5 k €	+179%	-26 k €	-40.5%	-18,5 k €	-183%	22,2 k €	+1051%	-2,3 k €	-111%	20,7 k €	-42.6%	36,2 k €	+50.9%	24 k €	-32.4%	35,5 k €	+105%	17,3 k €	-59.1%	42,2 k €	+261%	11,7 k €	-78.9%	55,4 k €	+76.0%	31,5 k €	-25.9%	42,5 k €	+1.0%	42,1 k €
Net result	20,2 k €	+181%	-24,9 k €	-16.9%	-21,3 k €	-273%	12,3 k €	+249%	-8,2 k €	-253%	5,4 k €	-61.2%	13,9 k €	+193%	4,8 k €	-73.5%	17,9 k €	+1972%	864,8 €	-94.6%	15,9 k €	-5.1%	16,7 k €	-41.7%	28,7 k €	+55.5%	18,5 k €	-35.2%	28,5 k €	-21.3%	36,2 k €
Balance sheet
Equity	438,7 k €	+2.0%	430,1 k €	-5.5%	454,9 k €	-4.5%	476,2 k €	+3.0%	462,2 k €	-1.8%	470,5 k €	+1.2%	465,1 k €	+3.1%	451,1 k €	+1.1%	446,4 k €	+4.2%	428,5 k €	+0.2%	427,6 k €	+3.9%	411,7 k €	+4.2%	395 k €	+7.8%	366,3 k €	+5.3%	347,8 k €	+8.9%	319,3 k €
Total assets	597 k €	+0.2%	595,9 k €	-45.5%	1,1 M €	+56.9%	697 k €	-19.5%	865,6 k €	+1.4%	853,7 k €	-15.3%	1 M €	-4.5%	1,1 M €	-10.6%	1,2 M €	-3.9%	1,2 M €	+16.7%	1,1 M €	-2.5%	1,1 M €	+7.9%	1 M €	+24.8%	801,6 k €	+46.3%	547,9 k €	+10.8%	494,4 k €
Cash	23,1 k €	-18.8%	28,5 k €	+29.1%	22,1 k €	-37.5%	35,3 k €	+33.1%	26,5 k €	-46.4%	49,5 k €	-9.2%	54,5 k €	+31.1%	41,6 k €	-16.5%	49,8 k €	-67.8%	155 k €	+380%	32,3 k €	-23.2%	42,1 k €	+118%	19,3 k €	-67.6%	59,7 k €	+394%	12,1 k €	-35.5%	18,7 k €
Debts	155,3 k €	+0.9%	153,9 k €	-73.8%	587 k €	+191%	201,6 k €	-48.7%	392,8 k €	+4.2%	376,9 k €	-30.0%	538,2 k €	-10.0%	597,7 k €	-15.7%	709,1 k €	-9.9%	786,8 k €	+31.6%	597,8 k €	-10.5%	667,7 k €	+15.2%	579,7 k €	+41.2%	410,5 k €	+105%	200,1 k €	+14.3%	175,1 k €
Other
Workforce	14,4 ETP	+4.3%	13,8 ETP	0.0%	13,8 ETP	+10.4%	12,5 ETP	+6.8%	11,7 ETP	+6.4%	11,0 ETP	-3.5%	11,4 ETP	0.0%	11,4 ETP	-3.4%	11,8 ETP	-2.5%	12,1 ETP	+8.0%	11,2 ETP	-1.8%	11,4 ETP	-0.9%	11,5 ETP	+1.8%	11,3 ETP	+15.3%	9,8 ETP	+3.2%	9,5 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€

See the valuation

Governance

Board of directors

Seen on filing of 30/06/2025 · 3 active · 8 ended

Active mandates

Maxim Parizel

Director · since 16 septembre 2020

Active

Christel De Meyere

Director

Active

Fabrice Lockefeer

Director

Active

Ended mandates

DOKTER FABRICE LOCKEFEER

Manager · since 01 avril 2012 · 0892.648.141

Ended

Christel DE MEYERE

Manager · since 26 juillet 1995

Ended

Karina CHARELS

Manager · since 14 juillet 1995

Ended

Christel De Meyere

Manager

Ended

At this address

Other companies at this address

Company	CBE no.
MEDEXPATH● Active	0848.059.122
PATHMEDEX GROEP● Active	0788.388.284

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/07/2024	01/07/2023	01/07/2022	01/07/2021	01/07/2020	01/07/2019
Closing of the financial year	30/06/2025	30/06/2024	30/06/2023	30/06/2022	30/06/2021	30/06/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	28/01/2026	30/01/2025	31/01/2024	31/01/2023	21/02/2022	26/02/2021
General meeting	13/01/2026	14/01/2025	23/01/2024	02/01/2023	26/01/2022	09/02/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	30/06/2025	13/01/2026	28/01/2026	Dutch	PDF
Abridged model	30/06/2024	14/01/2025	30/01/2025	Dutch	PDF
Abridged model	30/06/2023	23/01/2024	31/01/2024	Dutch	PDF
Abridged model	30/06/2022	02/01/2023	31/01/2023	Dutch	PDF
Abridged model	30/06/2021	26/01/2022	21/02/2022	Dutch	PDF
Abridged model	30/06/2020	09/02/2021	26/02/2021	Dutch	PDF
Abridged model	30/06/2019	16/01/2020	12/02/2020	Dutch	PDF
Abridged model	30/06/2018	25/01/2019	14/02/2019	Dutch	PDF
Abridged model	30/06/2017	07/02/2018	20/02/2018	Dutch	PDF
Abridged model	30/06/2016	30/12/2016	30/01/2017	Dutch	PDF
Abridged model	30/06/2015	28/12/2015	18/01/2016	Dutch	PDF
Abridged model	30/06/2014	30/12/2014	14/01/2015	Dutch	PDF
Abridged model	30/06/2013	31/12/2013	31/01/2014	Dutch	PDF
Abridged model	30/06/2012	31/12/2012	30/01/2013	Dutch	PDF
Abridged model	30/06/2011	30/12/2011	30/01/2012	Dutch	PDF
Abridged model	30/06/2010	15/01/2011	15/02/2011	Dutch	PDF
Abridged model	30/06/2009	28/12/2009	19/01/2010	Dutch	PDF
Abridged model	30/06/2008	13/01/2009	13/02/2009	Dutch	PDF
Abridged model	30/06/2007	28/12/2007	25/01/2008	Dutch	PDF
Abridged model	30/06/2006	29/12/2006	25/01/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 30/06/2025 · 3 active · 8 ended

Active mandates

Maxim Parizel

Director · since 16 septembre 2020

Active

Christel De Meyere

Director

Active

Fabrice Lockefeer

Director

Active

Ended mandates

DOKTER FABRICE LOCKEFEER

Manager · since 01 avril 2012 · 0892.648.141

Ended

Christel DE MEYERE

Manager · since 26 juillet 1995

Ended

Karina CHARELS

Manager · since 14 juillet 1995

Ended

Christel De Meyere

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates17/07/2024
ONTSLAGEN - BENOEMINGEN
PDF
Other17/02/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - DOEL
PDF
Mandates12/04/2022
ONTSLAGEN - BENOEMINGEN
PDF
Mandates03/11/2020
ONTSLAGEN - BENOEMINGEN
PDF
Mandates18/07/2012
ONTSLAGEN - BENOEMINGEN
PDF
Mandates19/10/2011
MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares20/02/2004
ALGEMENE VERGADERING - KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202520,2 k €↑
2024
Annual accounts 2024-24,9 k €↓
2023
Annual accounts 2023-21,3 k €↓
2022
Annual accounts 202212,3 k €↑
2018
Annual accounts 2018-8,2 k €↓
2017
Annual accounts 20175,4 k €↓
2016
Annual accounts 201613,9 k €↑
2015
Annual accounts 20154,8 k €↓
2014
Annual accounts 201417,9 k €↑
2013
Annual accounts 2013864,8 €↓
2012
Annual accounts 201215,9 k €↓
2011
Annual accounts 201116,7 k €↓
2010
Annual accounts 201028,7 k €↑
2009
Annual accounts 200918,5 k €↓
2008
Annual accounts 200828,5 k €↓
2007
Annual accounts 200736,2 k €
15/11/1982
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Cytopat

Overview

What does Cytopat do?

Trend over 16 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline